Skip to main content

Articles

Page 2 of 11

  1. The Japanese Society for Dialysis Therapy is conducting the survey annually since 1968. The results provide a comprehensive picture of dialysis therapy in Japan. The survey for the year 2019 was performed as o...

    Authors: Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Tetsuya Ogawa, Eiichiro Kanda, Kan Kikuchi, Shunsuke Goto, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Junichi Hoshino, Kenichiro Miura, Atsushi Wada and Yoshiaki Takemoto
    Citation: Renal Replacement Therapy 2023 9:47
  2. Although transcatheter aortic valve implantation (TAVI) is assumed to be a less invasive therapy in high-risk patients with aortic valve stenosis (AS), there have been limited data suggesting its beneficial ef...

    Authors: Masahiro Sakai, Koichi Hayashi, Yuki Hara, Akihiro Miyake, Keisuke Takano, Taro Hirai, Michi Kobayashi, Keita Endo, Kaede Yoshino, Koichi Kitamura, Shinsuke Ito, Tatsuya Ikeda, Yasuhiro Suzuki, Joji Ito, Kotaro Obunai, Hiroyuki Watanabe…
    Citation: Renal Replacement Therapy 2023 9:46
  3. Acute kidney injury (AKI) is an emerging public health problem worldwide and is associated with high morbidity and mortality. The high mortality rate can be attributed to the lack of pharmacological therapies ...

    Authors: Shigeo Negi, Tatsuya Wada, Naoya Matsumoto, Jun Muratsu and Takashi Shigematsu
    Citation: Renal Replacement Therapy 2023 9:45
  4. Compassionate care is one of the concepts that is important to the care of patients with chronic diseases, especially for patients undergoing hemodialysis who deal with all kinds of problems and sufferings. Th...

    Authors: Shayan Nikpey, Mansour Ghafourifard and Akram Ghahramanian
    Citation: Renal Replacement Therapy 2023 9:43
  5. Propofol is commonly used for sedation in the Intensive Care Unit (ICU). When administered in high doses and for a prolonged time, it can cause a rare but hazardous complication: Propofol Infusion Syndrome (PR...

    Authors: Marjorie Gosdal Zambon, Luana Caroline Miantti Ghellere Bonfim, Isadora Schwaab Guerini and Marcela de Almeida Lopes
    Citation: Renal Replacement Therapy 2023 9:42
  6. Alactic base excess (ABE) is a novel biomarker that estimates the renal capability of handling acid–base alterations during the sepsis. Hence, the aim of this study was to evaluate the use of ABE to predict th...

    Authors: Jesús S. Sánchez Díaz, Karla Gabriela Peniche Moguel, Fabiola Buelna Gaxiola, José M. Reyes Ruiz, Orlando R. Pérez Nieto and María V. Calyeca Sánchez
    Citation: Renal Replacement Therapy 2023 9:41
  7. Walking ability is an important prognostic factor for patients undergoing maintenance hemodialysis (HD). Since complications such as poor nutrition, anemia, malnutrition, and inflammation in patients undergoin...

    Authors: Hiroki Yabe, Haruka Nakano, Tomoya Yamaguchi, Ren Takahashi, Kenichi Kono, Yoshifumi Moriyama and Tetsuya Yamada
    Citation: Renal Replacement Therapy 2023 9:40
  8. Hemodialysis-associated pruritus (HAP) occurs in 60–80% of hemodialysis patients. This significant complication not only decreases quality of life through sleep disturbance and depression, but also leads to po...

    Authors: Naoko Takahashi, Jun Mano, Kenta Uchida, Taku Yoshizawa, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi and Takao Masaki
    Citation: Renal Replacement Therapy 2023 9:39
  9. Hemodialysis patients have chronic kidney disease, are often elderly, and have many complications such as hypertension, type 2 diabetes, cardiac disease, and cerebrovascular disease. Therefore, hemodialysis pa...

    Authors: Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida, Yasunori Suzuki and Shinya Hibino
    Citation: Renal Replacement Therapy 2023 9:38
  10. Therefore, reports on the risk of HTLV-1-related diseases in organ transplantation have increased in recent years, and the management of HTLV in renal transplantation remains a challenge.

    Authors: Noriaki Kawano, Yamada Kyohei, Hiroaki Miyoshi, Noriaki Yoshida, Kouichi Ohshima, Fumiko Arakawa, Kazutaka Nakashima, Takuro Kameda, Yasunori Kogure, Yuta Ito, Shuro Yoshida, Takuro Kuriyama, Takashi Nakaike, Taro Tochigi, Ken Takigawa, Kiyoshi Yamashita…
    Citation: Renal Replacement Therapy 2023 9:36
  11. The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with ...

    Authors: Gaetano Alfano, Niccolò Morisi, Camilla Ferri, Francesco Fontana, Silvia Giovanella, Giulia Ligabue, Giacomo Mori, Erica Franceschini, Annachiara Ferrari, Mariacristina Gregorini, Gianni Cappelli, Sara Tagliazucchi, Monica Pecorari, Giovanni Guaraldi, Riccardo Magistroni and Gabriele Donati
    Citation: Renal Replacement Therapy 2023 9:35
  12. Preventing peritoneal dialysis (PD)-associated peritonitis remains a major concern in continuing safe treatment and improving patient quality of life. This study aimed to determine the self-care education and ...

    Authors: Haruna Kugai, Ayumi Igarashi, Saori Anezaki, Chie Fukui, Nami Saito, Yoshifumi Hamasaki and Noriko Yamamoto-Mitani
    Citation: Renal Replacement Therapy 2023 9:34
  13. When polymethyl methacrylate (PMMA) membranes are used in continuous renal replacement therapy, especially in patients with high cytokine levels, inflammatory cytokines and other substances are removed by the ...

    Authors: Yoshitaka Kurihara, Kenichi Kokubo, Yuta Kobayashi, Yosuke Ushiroda, Shunichi Ueki, Hiroshi Tsukao, Kozue Kobayashi, Masaru Kubota and Hirosuke Kobayashi
    Citation: Renal Replacement Therapy 2023 9:33
  14. Survival is equivalent between super high-flux hemodialysis (SHF-HD) and online hemodiafiltration (OHDF) with similar albumin leakage. According to the 2013 Japanese dialyzer performance classification, surviv...

    Authors: Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Tomoko Inoue, Hisato Shima, Jun Minakuchi and Shu Kawashima
    Citation: Renal Replacement Therapy 2023 9:32
  15. In 2022, the government approved the telemedicine system for peritoneal dialysis (PD) in Japan in the form of medical fees. In 2000, we completed a telemedicine system for PD using an automatic peritoneal dial...

    Authors: Hidetomo Nakamoto, Ryutaro Aoyagi, Takeru Kusano, Takehito Kobayashi and Munekazu Ryuzaki
    Citation: Renal Replacement Therapy 2023 9:31
  16. Approximately 340,000 people in Japan are on chronic dialysis, and this number continues to increase. Even today, hemodialysis is the most frequently selected modality for renal replacement therapy in Japan, a...

    Authors: Yuki Kawaguchi, Norio Hanafusa and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2023 9:29
  17. Clarification of the factors associated with decreased physical activity is crucial for effective disease management in patients undergoing hemodialysis. Although evidence suggests that physical activity may b...

    Authors: Yusuke Matsunaga, Yuta Suzuki, Shohei Yamamoto, Keigo Imamura, Shun Yoshikoshi, Manae Harada, Toshiki Kutsuna, Kentaro Kamiya, Atsushi Yoshida, Kanako Ichikura, Yuko Fukase, Norio Murayama, Hirokuni Tagaya and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2023 9:28
  18. In accordance with the United Nations' 2030 Agenda for Sustainable Development and Japan's Diet Members Caucus on Global Health, we prepared a report and recommendations for nephrology nursing care in the cont...

    Authors: Nadami Mimura, Yoshiko Takuwa, Yui Tamura, Harumi Kawamura, Misato Nishimura and Noriko Yamaguchi
    Citation: Renal Replacement Therapy 2023 9:27
  19. Pediatric continuous kidney replacement therapy (CKRT) uses blood as the priming fluid in the CKRT circuit to prevent hemodilution and hypotension and is dialyzed using a dialysate before the start of CKRT. Th...

    Authors: Hiroyuki Nagafuchi, Kenta Shono, Hiroyuki Shimizu, Kaori Yamada, Aya Kajihama, Sakura Minami and Kyosuke Sasaki
    Citation: Renal Replacement Therapy 2023 9:26
  20. Plasma exchange (PEX) has been the primary treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) since the 1990s. Daily PEX is recommended in international guidelines, but PEX was only reimb...

    Authors: Yuji Yamada, Hiroyuki Ohbe, Hideo Yasunaga, Hidetomo Nakamoto and Yoshitaka Miyakawa
    Citation: Renal Replacement Therapy 2023 9:25
  21. Heart failure is a clinical syndrome with considerable morbidity and mortality rates. Recent data published by National Health and Nutrition Examination Survey (NHANES) showed that 6 million Americans are diag...

    Authors: Aneeqa Javed, Muhammad Junaid Alvi, John Afif, Suzanne Elsayegh, Syeda Sahra and Elie El-Charabaty
    Citation: Renal Replacement Therapy 2023 9:24
  22. Hemodiafiltration (HDF) therapy has become standard treatment in Japan and Europe, but evidence from Europe is not directly applicable to HDF in Japan because HDF therapy differs greatly in the two regions. Ja...

    Authors: Toshihide Naganuma, Yoshiaki Takemoto, Naohiro Kamada and Hideki Kawanishi
    Citation: Renal Replacement Therapy 2023 9:23
  23. CCE is a systemic disease with poor prognosis with no established treatment. Approximately 23–32% of CCE cases progress to end-stage renal failure, and the 1-year mortality rate of CCE with organ failure is 60...

    Authors: Yumiko Kawai, Chiharu Kinoshita, Koichi Matsuda, Keiko Takeuchi, Yoshimoto Inoue and Yoko Fujita
    Citation: Renal Replacement Therapy 2023 9:22
  24. Although the angiotensin receptor-neprilysin inhibitor sacubitril-valsartan has demonstrated a valuable effect on cardiac function in patients with heart failure with a reduced ejection fraction, the effect of...

    Authors: Shoichiro Daimon, Yuka Sakamoto, Miyuki Yasuda and Mitsuhiro Nishitani
    Citation: Renal Replacement Therapy 2023 9:19
  25. Stenotrophomonas maltophilia (S. maltophilia) is being increasingly recognized as an important cause of nosocomial infections, particularly in immunocompromised patients, such as patients undergoing dialysis. S. ...

    Authors: Hisato Shima, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Maho Iwaki, Seiichiro Wariishi, Kazuyoshi Okada, Toshio Doi and Jun Minakuchi
    Citation: Renal Replacement Therapy 2023 9:18
  26. End-stage renal disease (ESRD) is serious global public health challenge in many developing countries. Treatment of ESRD is carried out through renal replacement therapy like peritoneal dialysis (PD). Depressi...

    Authors: Sepehr Bazazzadeh, Mohammad Reza Sharbafchi, Maryam Kazemi Naeini, Sayed Mohsen Hosseini, Abdolamir Atapour and Mojgan Mortazavi
    Citation: Renal Replacement Therapy 2023 9:17
  27. Autism spectrum disorder (ASD) is a common communication disorder, with an incidence rate of 3%. In most cases, clinicians can diagnose ASD in a single outpatient visit. However, in the case of ASD patients wi...

    Authors: Yuko Fujii, Hideki Matsumura, Akihiko Shirasu, Hyogo Nakakura, Satoshi Yamazaki, Tetsufumi Kanazawa, Nanako Saito, Hajime Hirano, Haruhito Azuma, Kandai Nozu and Akira Ashida
    Citation: Renal Replacement Therapy 2023 9:16
  28. As there is no established standard of care for non-tuberculous mycobacterium (NTM) peritoneal dialysis (PD)-related peritonitis, its treatments have to be case-dependent, which is often difficult. Additionall...

    Authors: Tomoki Nagasaka, Kiyotaka Uchiyama, Ryoichi Shirai, Ryunosuke Mitsuno, Tomomi Maruki, Eriko Yoshida Hama, Erina Sugita, Ei Kusahana, Rena Sumura, Takashin Nakayama, Satoshi Kinugasa, Kohkichi Morimoto, Yoshitaka Ishibashi, Naoki Washida and Hiroshi Itoh
    Citation: Renal Replacement Therapy 2023 9:15
  29. The spread of coronavirus disease 2019 (COVID-19) has dramatically altered the lifestyles of many people worldwide. Several studies reported that body weight of young adults increased during the COVID-19 pande...

    Authors: Narumi Fukuzaki, Yuta Suzuki, Juri Uchida, Takuya Nakajima, Shohei Yamamoto, Keigo Imamura, Shun Yoshikoshi, Manae Harada, Ryota Matsuzawa, Kentaro Kamiya and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2023 9:12
  30. That the prevalence of low triiodothyronine (T3) syndrome is high among hemodialysis (HD) patients has been previously established. Herein, we examined the association of glycated albumin (GA) and the GA to gl...

    Authors: Keiji Mimura, Takahiro Nishide, Toshihide Naganuma, Yui Katsube, Seiji Ishitani, Katsuhiko Nakahara, Naohisa Hirasaka, Rie Mizobata, Yuko Yamagata, Osamu Nishikawa and Susumu Yukawa
    Citation: Renal Replacement Therapy 2023 9:11
  31. Haemodialysis (HD) patients are at increased risk of frailty, sarcopenia and protein energy wasting, all associated with increased mortality. Most of the dialysis day is taken up with travelling to and from di...

    Authors: Andrew Davenport
    Citation: Renal Replacement Therapy 2023 9:10
  32. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disorder characterized by asthma, eosinophilia, and systemic vasculitis. Renal involvement is not regarded as a prominent feature and the treatmen...

    Authors: Ryuichi Yoshii, Kengo Kajiwara, Naomichi Uemura, Koki Matsushita, Tomohumi Nakamura, Masao Tomita and Masashi Mukoyama
    Citation: Renal Replacement Therapy 2023 9:9
  33. Conventional hemodialysis (HD) for kidney failure patients with severe hyponatremia may be complicated by rapid correction of hyponatremia, which increases the risk of osmotic demyelination syndrome. A simple ...

    Authors: Mohamed Sary Gharib
    Citation: Renal Replacement Therapy 2023 9:8
  34. Patients on haemodialysis are predisposed to heart rhythm disorders, including bradyarrhythmia, atrial fibrillation (AF)/atrial flutter, supraventricular/ventricular arrhythmias and sudden cardiac death (SCD) ...

    Authors: Emi Anno, Yukihiro Sato, Ainori Hoshimoto, Makiko Harano, So Hagiwara, Eri Imai, Shuzo Kaneko and Yusuke Tsukamoto
    Citation: Renal Replacement Therapy 2023 9:7
  35. Cardiorespiratory fitness seems to play an important role in the general health of patients undergoing hemodialysis (HD). However, the prediction of peak oxygen uptake (V̇O2peak) in a clinical setting is not wide...

    Authors: Francini Porcher Andrade, Heitor Siqueira Ribeiro, Heloíse Benvenutti, Samantha Gonçalves de Oliveira, Fernando Saldanha Thomé, Francisco Veríssimo Veronese and Paula Maria Eidt Rovedder
    Citation: Renal Replacement Therapy 2023 9:6
  36. Peritonitis is a serious and potentially fatal complication of peritoneal dialysis. We report a case of fatal peritonitis caused by Mycobacterium mageritense that was detected for the first time in peritonitis.

    Authors: Nobuhiro Hashimoto, Nao Kani, Shuzo Makino, Tomoya Naka, Hiromitsu Miyakawa, Kazuhiro Okamoto, Ryuta Uwatoko, Saki Bessho, Rei Iio, Yoshiyasu Ueda and Terumasa Hayashi
    Citation: Renal Replacement Therapy 2023 9:5
  37. Non-cuffed hemodialysis (HD) catheters are often used for emergency or temporary vascular access. Its complications include thrombosis and catheter-related bloodstream infection (CRBSI); however, thrombophlebi...

    Authors: Shun Yoshida, Koichi Usui, Tsukasa Naganuma, Ikuo Nukui and Masakiyo Wakasugi
    Citation: Renal Replacement Therapy 2023 9:4
  38. Frailty has become an emerging public health problem in the aging society and is regarded as a state of vulnerability to developing increased dependency and/or mortality when exposed to a stressor. As the prop...

    Authors: Kosaku Nitta, Norio Hanafusa, Yuki Kawaguchi and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2023 9:2
  39. Post-transplant de novo thrombotic microangiopathy (TMA) is a rare yet serious complication that generally can develop in renal transplant recipients immediately after reperfusion or several months after transpla...

    Authors: Keisuke Ozaki, Tomoya Fukawa, Kunihisa Yamaguchi, Keito Shiozaki, Yutaro Sasaki, Sayo Ueda, Kohjiro Nagai, Shu Wakino, Masayuki Takahashi and Hiro-omi Kanayama
    Citation: Renal Replacement Therapy 2023 9:1
  40. Iron deficiency is widely present in patients with heart failure (HF) and is associated with an increased risk of mortality and poor clinical outcomes regardless of anemia. HF is highly prevalent in patients w...

    Authors: Kyoko Ito, Kenjiro Murakami, Ryoichi Yamada, Hiroyuki Susai and Noriaki Nishino
    Citation: Renal Replacement Therapy 2022 8:64
  41. Invasive aspergillosis (IA) is a severe form of fungal infection caused by the genus Aspergillus in immunocompromised hosts and has a high mortality rate. End-stage kidney disease (ESKD) is one of the risk factor...

    Authors: Noriaki Sato, Hideki Yokoi, Mitsuhiro Ichioka, Akira Ishii, Takeshi Matsubara and Motoko Yanagita
    Citation: Renal Replacement Therapy 2022 8:63
  42. The incidence of cardiovascular (CV) events is high in hemodialysis (HD) patients and is associated with hyporesponsiveness to erythropoiesis-stimulating agents (ESAs). However, there are no recommended target...

    Authors: Kosaku Nitta, Takahiro Kuragano, Nobuhiko Joki, Kazuhiko Tsuruya, Hirokazu Honda, Takayuki Hamano, Hideki Fujii, Yukari Uemura and Ken Tsuchiya
    Citation: Renal Replacement Therapy 2022 8:62

Annual Journal Metrics

  • 2022 Citation Impact
    1.2 - 2-year Impact Factor
    0.703 - SNIP (Source Normalized Impact per Paper)
    0.438 - SJR (SCImago Journal Rank)

    2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    137 days submission to accept (Median)

    2023 Usage 
    545,038 downloads
    139 Altmetric mentions